Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

METABOLIC DISEASE

Who knew? PPARs may act in the brain too

Nature Metabolism volumeĀ 4,Ā pages 965ā€“966 (2022)Cite this article

Subjects

New research shows that a drug conjugate that links the dual PPARš¯›¼/š¯›¾ agonist tesaglitazar to a GLP-1 receptor agonist has superior effects on weight loss and glucose metabolism compared with monotherapy in mice. The conjugate has actions in the hypothalamus that may contribute to its benefits.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Conjugates for the treatment of metabolic disease.

References

  1. Drucker, D. J. Cell Metab. 27, 740ā€“756 (2018).

    ArticleĀ  CASĀ  Google ScholarĀ 

  2. AhrĆ©n, B. et al. Diabetes Obes. Metab. 20, 2210ā€“2219 (2018).

    ArticleĀ  Google ScholarĀ 

  3. Kristensen, S. L. et al. Lancet Diabetes Endocrinol. 7, 776ā€“785 (2019).

    ArticleĀ  CASĀ  Google ScholarĀ 

  4. Jastreboff, A. M. et al. N. Engl. J. Med. https://doi.org/10.1056/NEJMoa2206038 (2022).

    ArticleĀ  PubMedĀ  Google ScholarĀ 

  5. Quarta, C. et al. Nat. Metab. https://doi.org/10.1038/s42255-022-00617-6 (2022).

    ArticleĀ  Google ScholarĀ 

  6. Kalliora, C. & Drosatos, K. J. Cardiovasc. Pharmacol. 76, 514ā€“526 (2020).

    ArticleĀ  CASĀ  Google ScholarĀ 

  7. Ryan, K. K. et al. Nat. Med. 17, 623ā€“626 (2011).

    ArticleĀ  CASĀ  Google ScholarĀ 

  8. Sarruf, D. A. et al. Endocrinol. 150, 707ā€“712 (2009).

    ArticleĀ  CASĀ  Google ScholarĀ 

  9. Adams, J. M. et al. Diabetes 67, 1538ā€“1548 (2018).

    ArticleĀ  CASĀ  Google ScholarĀ 

  10. Ludwig, M. Q. et al. Diabetes 70, 1945ā€“1955 (2021).

    ArticleĀ  CASĀ  Google ScholarĀ 

  11. MacDougald, O. A. & Lane, M. D. Annu. Rev. Biochem. 64, 345ā€“373 (1995).

    ArticleĀ  CASĀ  Google ScholarĀ 

  12. Tontonoz, P. & Spiegelman, B. M. Annu. Rev. Biochem. 77, 289ā€“312 (2008).

    ArticleĀ  CASĀ  Google ScholarĀ 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, University of Michigan, Ann Arbor, MI, USA

    Randy J. Seeley

  2. AstraZeneca, Gaithersburg, MD, USA

    Christopher J. Rhodes

Authors
  1. Randy J. Seeley
    View author publications

    You can also search for this author in PubMedĀ Google Scholar

  2. Christopher J. Rhodes
    View author publications

    You can also search for this author in PubMedĀ Google Scholar

Corresponding author

Correspondence to Randy J. Seeley.

Ethics declarations

Competing interests

R.J.S. receives research support from AstraZeneca, Novo Nordisk and Fractyl. R.J.S. has served as a paid consultant for Novo Nordisk, Scohia, CinRx, ShouTi Pharma and Fractyl. R.J.S. has equity in Calibrate and Rewind. This work was supported by NIH grants to R.J.S. P01DK117821 and P30DK089503. C.J.R. is an employee of AstraZeneca and owns AstraZeneca stock.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Seeley, R.J., Rhodes, C.J. Who knew? PPARs may act in the brain too. Nat Metab 4, 965ā€“966 (2022). https://doi.org/10.1038/s42255-022-00625-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s42255-022-00625-6

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter ā€” what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing